For example, positron emission tomography (PET) data suggest Aβ42 accumulation plateaus early in AD development (Jack et al., 2013), whereas tau accumulation continues to rise as clinical symptoms worsen (Mattsson et al., 2017). Here, MAPT is linked to Alzheimer disease.